XORTX Therapeutics annual return on equity
2020
2021
XORTX Therapeutics Return on Equity (ROE) Growth & History (XRTX)
XORTX Therapeutics's return on equity was −18.36% for fiscal 2021.
View full XORTX Therapeutics company overviewXORTX Therapeutics annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-12-31 | −18.36% | +227.60 pp |
| 2020 | 2020-12-31 | −245.97% | — |
XORTX Therapeutics return on equity trends
Between the periods ended 2020-12-31 and 2021-12-31, XORTX Therapeutics's return on equity increased from −245.97% to −18.36%, a change of +227.60 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review XORTX Therapeutics source filings ↗